Sigilon

Developer of therapeutics to treat chronic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups66 employees language sigilon.com

Registered entities

Investor mix

7 investors on record; lead investors include CPP Investments.

Investor typeCountShare
Venture capital457%
Other / undisclosed343%
Coming soon